Esmolol OrPha 100 mg/10 ml, Injektionslösung

7680574130025 CH-57413 Injektionslösung
Esmolol OrPha 100 mg/10 ml, Injektionslösung
Esmolol OrPha 100 mg/10 ml, Injektionslösung
Esmolol OrPha 100 mg/10 ml, Injektionslösung
1 / 3
google

Article details

Package size
5
Selling units
5
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
03/12/2020
Summary of Product Characteristics
Français
03/12/2020

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
7.88 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

OrPha Swiss GmbH

8700 Küsnacht ZH

Authorization information

Swissmedic authorization number
57413
Drug name
Esmolol OrPha, Injektionslösung
Galenic form
LSPA
ATC Code
C07AB09
Authorization status
Z
Dispensing category
B
First authorization
07/07/2006
Authorization expiration date
31/12/9999
IT Number
02.03.0.
Domain
Human medicine
Field of application
Betarezeptoren-Blocker

Package details

Description (FR)
ESMOLOL OrPha sol inj 100 mg/10ml 5 flac 10 ml
Description (DE)
ESMOLOL OrPha Inj Lös 100 mg/10ml 5 Durchstf 10 ml
Market launch
07/07/2006
Narcotic (BTM)
No

Other package sizes (1)

ESMOLOL OrPha conc perf 2.5 g/10ml amp 10 ml
1 AMP
GTIN: 7680574130049
Not in V1